Why the study?
Does in utero antiarrhythmic drug therapy improve venous blood flow velocity waveforms in fetuses with supraventricular tachycardia?
Population
11 fetuses (five with and six without hydrops) with supraventricular tachycardia
Comparison
In utero antiarrhythmic drug therapy vs Before drug treatment (baseline)
Design
Case_series
Authors
Loading...
May normalize venous flow in fetal SVT during sinus rhythm; hypothesis-generating and should not yet change practice.
Does in utero antiarrhythmic drug therapy improve venous blood flow velocity waveforms in fetuses with supraventricular tachycardia?
In utero antiarrhythmic therapy for fetal supraventricular tachycardia normalizes abnormal venous blood flow velocity waveforms.
Gembruch et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: